Abstract:New influenza vaccines have been designed based on the fact that the extracellular domain of M2 protein (M2e) is nearly invariant in all influenza A strains. To clarify which exact,region of M2e could induce antibodies with inhibitory activities against influenza virus replication, four overlapping peptides covering M2e were synthesized and then coupled to the carrier protein bovine serum albumin through the cysteine of the peptides. After a vaccination course, all these four peptide vaccines could induce high levels of rabbit antibodies with predefined peptide specificity (antibody dilution: 1: 6400-1:25 600). Besides, the anti-N-terminal antibodies (AS2) reacted strongly with M2e, and reacted weakly with the middle part and C-terminus of M2e. The MDCK assay for cytopathic effect proved that antibodies recognizing the N-terminus of M2e could obviously inhibit replication of influenza A virus (A/wuhan/359/95) and influenza B virus (B/wuhan/321/99) in vitro in a dose-dependent manner, while antibodies recognizing the middle part and the C-terminus of M2e did not show such significant inhibitory activities. Sequence analysis indicates that the first nine N-terminal amino acid residues of M2e are extremely conservative. Just this region containing the first nine amino acid residues could induce antibodies with inhibitory activity against influenza A and influenza B virus replication, suggesting that the N-terminus of M2e may contain an epitope that could induce inhibitory antibodies against influenza virus replication in vitro. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.

Crystal structure of the conserved amino-terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody.

Cryo-EM Structure of the SARS Coronavirus Spike Glycoprotein in Complex with Its Host Cell Receptor ACE2

Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.

Expression and initial structural insights from solid-state NMR of the M2 proton channel from influenza A virus.

Fine-epitope Mapping of an Antibody That Binds the Ectodomain of Influenza Matrix Protein 2

Universal Influenza Vaccine Based on the Extracellular Domain of M2 Protein

M2e-Based Universal Influenza A Vaccines

Crystal Structure of an Orthomyxovirus Matrix Protein Reveals Mechanisms for Self-Polymerization and Membrane Association.

Monoclonal Antibodies Recognizing EVETPIRN Epitope of Influenza A Virus M2 Protein Could Protect Mice from Lethal Influenza A Virus Challenge

X-Ray Crystal Structure Of The Influenza A M2 Proton Channel S31n Mutant In Two Conformational States: An Open And Shut Case

Crystal Structures Of Influenza A Virus Matrix Protein M1: Variations On A Theme

Initial Structural and Dynamic Characterization of the M2 Protein Transmembrane and Amphipathic Helices in Lipid Bilayers.

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines

The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

The cytoplasmic domain of influenza M2 protein interacts with caveolin-1.

M2e-specific Antibodies Protect Against Influenza PR8 Virus in an Isotype and Route Dependent Manner.

Monoclonal Antibody, but Not Synthetic Peptide, Targeting the Ectodomain of Influenza B Virus M2 Proton Channel Has Antiviral Activity

N-terminus of M2 Protein Could Induce Antibodies with Inhibitory Activity Against Influenza Virus Replication

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.

Characterization of Immunity Induced by M2e of Influenza Virus.

Two Polar Residues Within C-terminal Domain of M1 Are Critical for the Formation of Influenza A Virions.